Latest news

Synapse CEO announcement

Synapse Electroceutical today announced that the Board of Directors has appointed Andy Boyes as Interim Chief Executive Officer. John Gildersleeve will assume the role of Business Development Director and will continue to serve as an executive director on the Board.

Read this article
Become a Distributor

Andy Boyes appointed as Non-Executive Director to Synapse Electroceutical Limited

Synapse Electroceutical Limited is delighted to announce the appointment of Andy Boyes to the Board. Andy has enjoyed a successful, 32 year career at Smith & Nephew, the FTSE 100 medical technology business engaged in developing, manufacturing, marketing and selling medical devices in the Advanced Wound Management and Advanced Surgical Devices sectors with sales in excess of £4 billion. Andy is passionate
about the wound care sector and helping improve the lives of patients suffering with debilitating complex wounds and since leaving Smith & Nephew has focussed on providing Board level support and strategic direction in the sector.

Read this article

'Electrical stimulation therapy and electroceutical treatment for the management of venous leg ulcers’ published in Community Wound Care

The use of innovative technologies for transforming and improving clinical outcomes and reducing costs in the NHS was an integral component of the NHS Five Year Forward View (2014). The use of electroceutical treatment has been demonstrated to both improve patient outcomes and reduce costs to the NHS for the management of chronic wounds.

Read this article

Other articles

Information for Clinicians

Accel-Heal product shot